Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Stomach Neoplasms 5 Urinary Bladder Neoplasms 4 Colorectal Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 2 HER2-positive Gastric Cancer 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Neoplasms 1 Muscle Invasive Bladder Carcinoma 1 Muscle Invasive Bladder Cancer (MIBC) 1 Muscle Invasive Bladder Cancer 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Lung Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 HER2-low Breast Cancer 1 HER2 1 Gastric Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Breast Cancer 1

Interventions

Carboplatin 156 Paclitaxel 154 Bevacizumab 96 Cyclophosphamide 61 Gemcitabine 46 olaparib 45 Cisplatin 45 Topotecan 44 niraparib 40 liposomal doxorubicin 40 pembrolizumab 38 Surveys and Questionnaires 33 Filgrastim 31 Hyperthermic Intraperitoneal Chemotherapy 29 Docetaxel 27 Taxes 25 Blood Specimen Collection 24 fludarabine 23 Drug Therapy 23 Cytoreduction Surgical Procedures 23 Peripheral Blood Stem Cell Transplantation 21 Etoposide 21 Doxorubicin 21 Magnetic Resonance Spectroscopy 20 durvalumab 17 Specimen Handling 17 Albumin-Bound Paclitaxel 17 Immunoglobulin G 15 Disulfides 15 Letrozole 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Neoplasms × disitamab vedotin × Clear all

NCT06540729 2025-07-08

DAB

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡